Boundless Bio to Participate in the Piper Sandler Healthcare Conference
Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company focused on extrachromosomal DNA (ecDNA) biology and oncogene amplified cancers, has announced its participation in Piper Sandler's 36th Annual Healthcare Conference.
President and CEO Zachary Hornby will participate in a fireside chat on Wednesday, December 4, 2024, at 3:30 p.m. ET in New York. The session will be available via live and archived webcast through the company's website under the Investors section.
Boundless Bio (Nasdaq: BOLD), un'azienda oncológica in fase clinica focalizzata sulla biologia del DNA estracromosomico (ecDNA) e sui tumori amplificati da oncogeni, ha annunciato la sua partecipazione alla 36ª Conferenza Annuale sulla Salute di Piper Sandler.
Il presidente e CEO Zachary Hornby parteciperà a una chiacchierata informale mercoledì, 4 dicembre 2024, alle 15:30 ET a New York. La sessione sarà disponibile tramite webcast in diretta e registrato attraverso il sito web dell'azienda nella sezione Investitori.
Boundless Bio (Nasdaq: BOLD), una empresa oncológica en etapa clínica centrada en la biología del ADN extracromosómico (ecDNA) y en los cánceres amplificados por oncogenes, ha anunciado su participación en la 36ª Conferencia Anual de Salud de Piper Sandler.
El presidente y CEO Zachary Hornby participará en una charla informal el miércoles, 4 de diciembre de 2024, a las 3:30 p.m. ET en Nueva York. La sesión estará disponible a través de un webcast en vivo y grabado a través del sitio web de la empresa en la sección de Inversores.
Boundless Bio (Nasdaq: BOLD)는 엑스트라크로모좀 DNA (ecDNA) 생물학 및 온코진 증폭 암에 중점을 두고 있는 임상 단계의 종양학 회사로, Piper Sandler의 제36회 연례 헬스케어 컨퍼런스에 참여한다고 발표했습니다.
회장 겸 CEO인 자카리 혼비는 2024년 12월 4일 수요일 오후 3시 30분 ET에 뉴욕에서 열린 파이어사이드 채팅에 참석할 예정입니다. 이 세션은 회사 웹사이트의 투자자 섹션을 통해 생중계 및 녹화된 웹캐스트로 제공될 것입니다.
Boundless Bio (Nasdaq: BOLD), une entreprise d'oncologie en phase clinique axée sur la biologie de l'ADN extrachromosomique (ecDNA) et les cancers amplifiés par des oncogènes, a annoncé sa participation à la 36e Conférence Annuelle sur la Santé de Piper Sandler.
Le président-directeur général Zachary Hornby participera à une discussion informelle le mercredi 4 décembre 2024, à 15h30 ET à New York. La session sera disponible par le biais d'un webcast en direct et archivé sur le site web de l'entreprise dans la section Investisseurs.
Boundless Bio (Nasdaq: BOLD), ein klinisch tätiges Onkologieunternehmen, das sich auf die Biologie des extrachromosomalen DNA (ecDNA) und onkogen-amplifizierte Krebserkrankungen konzentriert, hat seine Teilnahme an der 36. jährlichen Gesundheitskonferenz von Piper Sandler angekündigt.
Präsident und CEO Zachary Hornby wird am Mittwoch, den 4. Dezember 2024, um 15:30 Uhr ET in New York an einem Fireside-Chat teilnehmen. Die Sitzung wird über einen Live- und Archiv-Webcast auf der Website des Unternehmens im Bereich Investoren verfügbar sein.
- None.
- None.
SAN DIEGO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced that Zachary Hornby, President and Chief Executive Officer, will participate in Piper Sandler’s 36th Annual Healthcare Conference.
A fireside chat session is scheduled for Wednesday, December 4, 2024, in New York, NY, at 3:30 p.m. ET. A live and archived webcast of the session will be accessible under “Events & Presentations” in the Investors section of Boundless Bio’s website and can be accessed via this link: https://event.webcasts.com/starthere.jsp?ei=1697442&tp_key=52e6709a8e.
About Boundless Bio
Boundless Bio is a clinical-stage oncology company dedicated to unlocking a new paradigm in cancer therapeutics to address the significant unmet need of patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than
For more information, visit www.boundlessbio.com.
Contacts:
Ben Flaum, Boundless Bio
bflaum@boundlessbio.com
Investors
THRUST Strategic Communications
Renee Leck
renee@thrustsc.com
FAQ
When is Boundless Bio (BOLD) presenting at the Piper Sandler Healthcare Conference 2024?
How can I watch Boundless Bio's (BOLD) presentation at the Piper Sandler Conference?
What type of cancer research does Boundless Bio (BOLD) focus on?
Who will represent Boundless Bio (BOLD) at the Piper Sandler Healthcare Conference?
